Does TRICARE Cover PRP Injections? 2024 Policy, Costs, and Appeals

TRICARE does not cover PRP injections. Provisional coverage for platelet-rich plasma ran from October 1, 2019, through September 30, 2024, and it was not renewed. As of 2026, TRICARE classifies PRP as unproven for all indications, meaning beneficiaries pay the full cost themselves.¹

What Changed in 2024

For five years, TRICARE covered PRP under its Provisional Coverage Program, but only for two conditions: mild to moderate chronic osteoarthritis of the knee and lateral epicondylitis (tennis elbow). Patients had to document that at least three months of conservative treatment, such as physical therapy, diet, or exercise, had failed or was medically contraindicated. Knee cases also needed radiographic evidence of osteoarthritis.²

Provisional coverage lasts up to five years, at which point the Assistant Secretary of Defense for Health Affairs decides whether to make the benefit permanent, extend it, or let it expire. For PRP, the decision was to let it expire. The TRICARE Policy Manual carries a termination date of September 30, 2024, and no reinstatement appears in the June 2025 update.³

TRICARE did not publish a rationale specific to PRP. In the wider clinical picture, PRP has no FDA approval for any specific indication; the devices that prepare PRP receive FDA clearance, but the plasma product itself is not approved for treating joint or tendon conditions. Systematic reviews have described the evidence as inconclusive, and most private insurers also treat PRP as experimental.⁴

What “Unproven for All Indications” Means for Your Claim

The current TRICARE classification is broader than the old coverage was. When PRP was covered, only knee osteoarthritis and tennis elbow qualified. Now the exclusion runs across every diagnosis. A 2026 TriWest policy document, covering TRICARE’s West Region, states plainly that “Platelet-rich plasma (PRP) is unproven for all indications,” with no exceptions.¹

Under TRICARE’s framework, a service is unproven when it has not been shown to be comparable or superior to conventional treatments, or when reliable safety and efficacy evidence has not been established. Claims for PRP will be denied whether the injection is for a knee, an elbow, a shoulder, an Achilles tendon, or any other site.

What PRP Will Cost You

A single PRP injection typically runs between $500 and $2,500. Because many treatment protocols call for one to three injections, the total out-of-pocket cost can reach $500 to $6,000.⁴

Some related services can still be billed to TRICARE separately. Office visits and evaluations for the underlying condition are generally covered, and the blood draw used to prepare the PRP may also be billable as its own procedure. Only the PRP preparation and injection itself falls under the exclusion.

Can You Appeal a PRP Denial?

The appeal path is narrow. When TRICARE denies a service based on a statutory or regulatory exclusion, you can challenge whether the exclusion was applied correctly to your claim, but you cannot challenge the exclusion itself.⁵ In practice, that means arguments about miscoding or misidentification of the procedure can be raised. Arguments that TRICARE should cover PRP despite its unproven classification cannot.

Reconsideration requests must be filed in writing within 90 calendar days of the denial notice, and contractors generally complete their review within 60 days.⁶ If the reconsideration upholds the denial on the basis of the exclusion, that decision “completes the administrative appeal process,” and no further formal review or hearing is available on the issue.⁵

Covered Alternatives for Knee and Tendon Pain

Several non-surgical treatments for the same conditions PRP used to cover remain covered:

Physical therapy, when medically necessary and provided by a licensed physical therapist or other qualified provider. General exercise or maintenance therapy is excluded, but goal-directed rehabilitation for a specific injury qualifies.⁷
Corticosteroid (cortisone) injections for joint pain, a standard covered treatment that often forms part of the conservative pathway TRICARE expects patients to try first.
Hyaluronic acid (viscosupplementation) injections for knee osteoarthritis. Prior authorization is required, along with an X-ray-confirmed diagnosis and documentation that conservative treatments have not brought sufficient relief. TRICARE Prime members need a referral from their Primary Care Manager.⁸
Oral NSAIDs and acetaminophen, as part of standard pain management.

TRICARE generally wants documentation that these conservative measures have been attempted before approving more advanced procedures, so working through the sequence with a TRICARE-authorized provider gives you the clearest path to covered care.

If You Also Use VA Care

The VA does not cover PRP either. It classifies the treatment as investigational for osteoarthritis, citing the lack of evidence and the absence of FDA approval for joint injections. Associated office visits and evaluations are covered, and some VA medical centers offer PRP at no cost through active clinical trials. Veterans interested in PRP can ask their VA provider whether any regenerative-treatment studies are open for enrollment.⁹

1
TriWest Healthcare Alliance. Unproven Services Policy Key
2
Defense Health Agency. TRICARE Policy Manual, Chapter 13, Section 1.1
3
Defense Health Agency. TRICARE Policy Manual, Chapter 13, Section 1.1
4
RGA. Global Health Brief – Platelet Rich Plasma: A Closer Look
5
Defense Health Agency. TRICARE Operations Manual, Chapter 12, Section 3
6
International SOS / TRICARE Overseas Program. Compliments, Grievances, and Appeals
7
TRICARE. Physical Therapy
8
TRICARE. Provisional Coverage
9
Healthline. Does Medicare Cover Platelet Rich Plasma Injections